Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults.
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study.
Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T lymphocyte acute lymphoblastic leukemia.
Pediatrics-General Pediatrics
Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces.
Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces. Front Oncol. 2023; 13:1187268.
View in:
PubMed
authors with profiles
Wendy Stock